Background: By shifting a greater share of out-of-pocket medical costs to consumers, high-deductible health plans (HDHP) might discourage use of essential outpatient services.
T he rapid expansion of high-deductible health plans (HDHPs) over the last decade is transforming the US insurance marketplace, yet understanding of their impact on access to care remains limited. From 2006 to 2012, the percentage of covered employees enrolled in a plan with at least a $1000 deductible more than tripled from 10% to 34%. 1 Among small firms, nearly 50% of workers were enrolled in HDHPs in 2012. 1 The implementation of the Patient Protection and Affordable Care Act (ACA) will likely accelerate HDHP adoption as employers seek to control costs 2 associated with current provisions 3 in the law-such as the expansion of dependent coverage for children up to age 26 and the elimination of annual and lifetime coverage limits-and as millions of uninsured Americans who are mandated to buy coverage by 2014 opt for lower premium HDHPs through an employer or health insurance exchanges. 4 Indeed, recent surveys confirm that many employers expect to pass these costs onto consumers by raising cost-sharing levels 5, 6 or offering a different plan 6 such as an HDHP. Higher patient cost sharing, however, has raised concerns that HDHPs might lead to unintended reductions in routine, effective care. 7 HDHPs shift costs to members by requiring full out-ofpocket payments for many services until an annual deductible has been met. Certain services, such as primary care visits, preventive screening, and prescription drugs, are often excluded from the deductible in such plans and, similar to traditional health plans, available for moderate or no cost sharing. 1 For preventive services, this arrangement will likely become more prevalent as a result of the ACA, which requires most health plans to offer certain preventive care without deductibles or other cost sharing. 1 In 2012, the average annual deductibles for Health Maintenance Organization (HMO), Preferred Provider Organization, and Pointof-Service plans with deductible components ranged from $691 to $1014 for individuals and $1329 to $2163 for families. 1 HDHPs with tax-advantaged health fund accounts, such as Health Reimbursement Accounts or Health Savings Accounts, make up about half of the HDHP market and have significantly larger individual and family deductibles ($2086 and $3924, respectively). 1 The RAND Health Insurance Experiment established that cost sharing has substantial effects on the use of both essential and nonessential services and, in particular, that deductibles of all sizes can cause reductions in medical spending. 8 More recent studies focusing on outpatient care have found that enrollment in HDHPs can lead to moderate reductions in the use of services with full cost sharing under the deductible, such as certain medications. [9] [10] [11] [12] However, HDHPs that exempt and fully cover preventive services have been shown to preserve their use. [13] [14] [15] A few studies have examined the impact of HDHPs on outpatient visits and found moderate to significant declines in visits after enrollment in an HDHP plan. 11, 16, 17 However, the levels of cost sharing for outpatient visits were not clear in these studies, 11, 16, 17 and 2 of the studies examined members who voluntarily chose HDHPs, possibly leading to selection bias. 16, 17 No previous research has examined how HDHPs impact outpatient visits and commonly associated diagnostic tests that are both exempt and not exempt from the deductible. We investigated the impact of an employer-mandated switch from traditional HMOs to HDHPs on several types of outpatient services for acute and chronic conditions that had different cost-sharing levels: office visits with modest copayments, preventive laboratory tests with first-dollar coverage, and general lab tests and radiology tests with full cost sharing under a deductible. We hypothesized that the HDHP would have both intended effects such as preservation of fully covered preventive laboratory tests and reduction of lower-priority outpatient visits, as well as unintended effects such as reductions in higher-priority outpatient visits.
METHODS

Study Setting
On April 1, 2002, Harvard Pilgrim Health Care (HPHC), a nonprofit insurer in New England, began offering an HDHP to Massachusetts employers. The HDHP includes lower premiums 18 and annual deductibles of $500-$2000 for individual coverage and $1000-$4000 for family coverage. 19 Full coverage for services included under the deductible begins for individual members after they reach their individual deductible, or for family members after either they reach their individual deductibles or the family's combined expenses reach the family deductible. The HDHP provider network, referral policies, and copayment obligations for services exempt from the deductible are the same as for HPHC's traditional HMO plans.
Most institutional services (eg, emergency department visits and hospitalizations) and diagnostic procedures (eg, radiology tests and general laboratory tests) are subject to the deductible in the HDHP. 19 However, like traditional HMO plans, only modest copayments are charged for most outpatient visits, including routine examinations, urgent care visits, and specialist consultations. 19 These copayments must be paid whether or not the deductible has been met. Preventive services (eg, immunizations, mammograms, and preventive laboratory tests) have first-dollar coverage similar to traditional plans. 19 The HDHPs also include an annual outof-pocket maximum equal to twice the deductible amount but not <$2000 for individuals and $4000 for families. 19 
Study Design and Sample
We used a pre-post with comparison group study design to examine utilization rates of several outpatient services. Using previously established methods, 13, 20 we created a study cohort of HPHC members enrolled through Massachusetts employers that offered only a single type of HPHC insurance plan, reducing the influence of self-selection bias. The cohort comprised 2 groups of interest: an HDHP group and a control group. The HDHP group included members who were enrolled in traditional HMO plans during a 1-year baseline period between April 1, 2001 and August 14, 2007 and then experienced an employer-mandated switch to an HDHP. The date of switch defined the index date. Each person in the HDHP group was randomly matched to 8 contemporaneous HMO members on the basis of adult/child status and whether the plan was purchased through an independent broker. We assigned control members the same index date as their matched HDHP member. From this original cohort we selected 8916 HDHP members and 56,978 controls aged 18-63 years at baseline who were continuously enrolled for 12 months before and at least 12 months after the index date. To curtail the influence of outliers in our study, we excluded members whose baseline use of office visits, laboratory tests, or radiology tests was above the 99.5th percentile (n = 259).
We used propensity score matching with 1:1 caliper matching to minimize employer-level selection effects and further improve the comparability of observed characteristics between the study groups. 21, 22 Variables in the propensity score model and the ensuing match included all variables that predicted being employed in a firm that switched to an HDHP, including age, sex, neighborhood socioeconomic characteristic, health status, individual or family plan status (assessed at index date), 20 employer size (based on number of employees), 20 baseline copayment level for outpatient, emergency department, and hospital visits, total member health plan costs at baseline, and secular changes. We performed an exact match on the characteristic of having 1 of 4 major chronic diseases associated with significant morbidity and mortality to ensure adequate representation in our sample: diabetes, hypertension, hyperlipidemia, and chronic pulmonary disease (asthma or chronic obstructive pulmonary disease). We also accounted for whether a plan was purchased through an independent broker ("association" plan) by doing an exact match on this characteristic given that these very small employers purchase health plans in a different manner (through small business associations rather than directly from Harvard Pilgrim) and we have slightly less information on enrollees (such as whether they had access to Health Reimbursement Arrangements).
To derive neighborhood-based measures of socioeconomic status, we linked members' residential addresses to their 2000 US Census block group, a subdivision of census tracts containing an average of 1000 individuals. 20, 23 We created previously established categorical variables of neighborhood poverty status and education levels 20, 24 and a composite variable for socioeconomic status. 20 We defined a low socioeconomic status neighborhood as a census block group with >10% of households below poverty level or 25% of adult household members with less than a high school education. 20 To assess health status, we used the Johns Hopkins Adjusted Clinical Groups (ACG) Score, a validated index of morbidity burden based on member age, sex, and baseline International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) diagnoses. 25, 26 Relative to larger ACG scores, smaller scores indicate lower risk or greater health. We assumed that employer size, association status, and individual or family plan status were constant throughout the study.
We identified the 4 major chronic diseases on the basis of the presence of either 2 outpatient or 1 inpatient ICD-9 diagnoses during the baseline year, similar to previous studies. [27] [28] [29] [30] [31] [32] Our propensity-matched sample comprised 7953 HDHP members and their matched controls, of whom 1010 HDHP members and their matched controls had at least 1 of the 4 chronic diseases.
Outcome Measures
We calculated the mean number of services used per member per study year for outpatient office visits, preventive laboratory tests, general laboratory tests, and radiology tests using HPHC medical claims data.
Using a taxonomy developed by Fenton et al, 33 we characterized each office visit into one of the following ICD-9 diagnostic categories: acute condition, chronic condition, symptomatic or ill-defined condition, mental illness, preventive or pregnancy-related care, vision or hearing disorder, and dermatologic condition. We used the Fenton taxonomy to further classify acute and chronic condition visits as higher or lower priority, with higher-priority diseases being considered more likely to benefit from medical care than lower-priority diseases. 33 The classification system was originally derived from the Oregon Prioritized Health Services List, which included an evidence-based ranking of >700 diagnosis and treatment combinations according to the expected morbidity or mortality benefits of medical care. 33, 34 We identified preventive laboratory tests, general laboratory tests, and radiology tests in the claims data using Current Procedural Terminology (CPT) 2008, Standard Edition codes. 35 We included only claims that did not occur on dates of emergency department visits or hospitalizations. We identified preventive laboratory tests (that have full coverage under the HDHP) based on the HPHC benefit schedule. These included tests for HbA1C, microalbuminuria, cholesterol, lead exposure, routine urinalysis, routine hemoglobin, hepatitis C, prostate-specific antigen, a-fetoprotein, group B streptococcus, sexually transmitted diseases, and human immunodeficiency virus. We excluded fully covered Pap smear and fecal occult blood tests because we examined these in previous studies. 13 The remaining pathology or laboratory claims were classified as general laboratory tests. Radiology tests comprised all outpatient radiologic procedures except for pregnancy ultrasound and mammography, which were fully covered by the HDHP.
To assess which specific services might be affected by the plan switch, we identified the top 10 most common services in each outcome category at baseline, according to ICD-9 Clinical Classification Software (CCS) categories 36 (visits) and CPT codes (laboratory and radiology tests). The top 10 reasons for office visits (routine examination, affective diagnosis, other mental condition, upper respiratory infection, anxiety disorder, hypertension, connective tissue disorder, back problem, skin diagnosis, and joint disorder) accounted for 47.0% of all baseline visits, whereas the top 10 preventive laboratory tests, general laboratory tests, and radiology tests accounted for 81.8%, 41.1%, and 48.6% of their respective baseline totals. Owing to their clinical importance, we also identified the 10 most common chronic high-priority and lower-priority visit reasons, which accounted for 63.4% and 69.0% of their respective baseline totals.
The average total costs per test for the top 10 general laboratory and radiology tests (ie, tests with full cost sharing for HDHP members) during baseline were $11.80 and $49.07 (maximum: $261.80 and $768.36), respectively. Mean outpatient (office visit) copayment levels for the HDHP group were $15.20 during baseline and $20.00 in the follow-up year, whereas the corresponding copayments were $15.05 and $15.74 for the control group.
Statistical Analysis
We compared baseline characteristics of the study groups using t tests and w 2 tests. We tested whether changes in annual rates after the index date were statistically significant using Poisson regression and generalized estimating questions to control for correlations between the measurements for each sample member before and after the plan switch. The analytic model produced incidence rate ratios (IRRs) by comparing the mean rates in the first year after the index date and the baseline year. We calculated the differential change in the incidence rate between study groups by examining the interaction between study group and year. The exponentiated parameter estimate for the interaction term can be interpreted as the ratio of IRRs. For example, a ratio of IRRs of 0.89 would indicate an 11% relative reduction in use among the HDHP members compared with controls from baseline to follow-up.
As a post hoc analysis, we calculated the relative change in general laboratory tests per visit to investigate whether reductions were primarily driven by declines in visits or fewer tests per visit.
All models were left unadjusted because our propensity score match generated study groups that were closely matched at baseline (see Appendix, Supplemental Digital Content 1, http://links.lww.com/MLR/A583, which further describes our matching and analytic approach). The analyses were conducted using SAS version 9.3 (SAS Institute, Cary, NC) and we specified an a priori statistical significance level of P < 0.05. Table 1 shows similar demographic, health, and plan characteristics between the HDHP and control groups. Both study groups had a mean age of 44.8 and were balanced by sex. Most members in each group were in family plans and employed by small firms. About half of each group purchased insurance through an association plan. The mean ACG score and the proportion of members with diabetes, hypertension, hyperlipidemia, or chronic pulmonary disease were comparable between study groups. Most members in each group resided in neighborhoods characterized by higher socioeconomic status. About one third of members in both groups had baseline outpatient (office visit) copayment levels >$15 and inpatient copayment levels >$350.
RESULTS
Baseline Characteristics
Annual Changes in Utilization of Outpatient Services
Results from the Poisson regression models are shown in Table 2 . HDHP members experienced a 9% relative reduction in the use of all office visits (ratio of IRRs = 0.91; 95% confidence interval: 0.88, 0.94). The HDHP group showed similar relative reductions in visits for chronic higher-priority conditions (0.91; 0.85, 0.97), chronic lowerpriority conditions (0.89; 0.81, 0.99), symptomatic or illdefined conditions (0.88; 0.82, 0.95), and preventive or reproduction-related care (0.92; 0.87, 0.98) compared with controls. Changes in mean visits for the remaining Fenton categories including acute higher-priority and lower-priority conditions (0.93; 0.86, 1.01 and 0.93; 0.86, 1.01, respectively) were not statistically different between the study groups.
HDHP members experienced a significant 9% relative decline in the use of all general laboratory tests (0.91; 0.86, 0.97) but no detectable changes in preventive laboratory tests (0.97; 0.93, 1.02) or radiology tests (0.97; 0.91, 1.03). The number of general laboratory tests per visit did not change for HDHP members relative to controls (data not shown).
DISCUSSION
The growing prevalence of HDHPs has raised concerns about their impact on essential care. Our study investigated the effect of HDHPs on the use of outpatient visits and associated diagnostic services. Although exempting services from full cost sharing appeared to preserve the use of outpatient visits for acute care and preventive laboratory tests, relative rates of visits for chronic, symptomatic or ill-defined conditions, and preventive or reproduction-related care declined, driving a 9% relative reduction in outpatient visits. Full cost sharing was associated with reduced use of general laboratories but not radiology tests.
Our findings suggest that enrollment in an HDHP was associated with both intended and unintended consequences, largely consistent with previous research on the effects of increased cost sharing. 8 Unchanged rates of high-priority acute visits and preventive laboratory tests indicate that these services can be preserved under HDHPs that exempt them from the deductible. Relative reduction in lower-priority chronic visits such as upper respiratory or osteoarthritic conditions may indicate potential cost savings without impacts on quality. In contrast, relative reductions in chronic higher-priority visits for conditions such as hypertension and asthma might represent a deferral of essential care that could increase future morbidity and costs. We are unable to conclude whether the observed relative changes in general laboratory test utilization were appropriate or inappropriate, as this assessment requires detailed clinical information not available in claims data.
Our study provides evidence of indirect reductions in health care services not subject to the deductible. In particular, office visits for HDHP members were selectively excluded from the deductible and available for copays of $20, yet relative reductions occurred in rates of chronic visits, visits associated with symptomatic or ill-defined conditions, and preventive or reproduction-related care. One hypothesis to be tested in future research is that members with these conditions incurred higher costs from associated services (such as general laboratory tests and radiology tests) after transition to HDHPs, which led indirectly to subsequent reductions in future visits. Similarly, it would be useful to examine whether the unexpected decline in visits for preventive or reproduction-related care was because of costs from services associated with reproduction-related care visits (for example, contraceptive, prenatal, or menopause services).
HDHP members preserved preventive laboratory tests with first-dollar coverage despite reductions in overall outpatient visits, possibly indicating awareness of the "valuebased" incentives of the HDHP. Reductions in general laboratory tests (which were subject to the deductible) could similarly indicate price awareness, but reasons for this reduction deserve scrutiny and raise the general question of whether patterns we detected were primarily patient or provider driven.
A key policy and research question is whether HDHPs can stimulate "activated consumers" who selectively maintain or increase high-value care at the expense of low-value care. Outpatient care is a good setting in which to examine this because patients generally have discretion in undergoing the types of services we examined. Because we detected reductions in care, a preliminary question is whether these were primarily patient or provider driven. Because HDHP members had financial incentives to reduce utilization after the index date while their providers did not, any reductions were likely driven by HDHP patients. To further understand the reductions, it is helpful to consider visits and testing as 2 distinct categories because of differing patient-provider influences on utilization decisions. Reductions in outpatient visits would be patient driven almost by definition because patients must usually decide independently whether to present (although decision support resources such as telephone triage are sometimes available). Here, we did not find evidence that patients made distinctions in visits by appropriateness given the similar level of reductions in both high-priority and low-priority care ( Table 2) . Outpatient testing usually involves joint patientprovider decisions at the point of care, so that the reductions we detected could indicate either that patients made a decision . HDHPs therefore might primarily have a "gatekeeper" effect on certain outpatient services by means of reducing contact with the system. Contrary to our hypothesis, HDHP members did not experience significant reductions in the use of radiology tests, relatively expensive services that were subject to full cost sharing. This result might be related to preservation of certain types of outpatient visits (eg, if such tests occurred predominantly during acute care visits), to patients' perceptions of the relative importance of radiology tests, or to the fact that many physicians order films to be completed and interpreted while patients wait.
Previous studies of HDHPs and outpatient care have also found that HDHPs protect the use of preventive services that have first-dollar coverage, such as breast, 13, 14 cervical, [13] [14] [15] and colorectal cancer screening 13, 15 ; child wellness visits 15 ; and diabetic monitoring. 14 A recent large study found small but statistically significant reductions in preventive care, including immunizations, cancer screening, and diabetes HbA1c measurement, after HDHP enrollment, but cost sharing levels for these services were uncertain and study members could have selected into HDHPs. 37 In addition, although HDHP enrollment has been shown to reduce the use of certain medications that fall under the deductible, [9] [10] [11] [12] utilization is generally preserved for exempted medications that have only modest 3-tiered copayments. 38 This evidence, along with the findings of our study, may suggest that patients are able to maintain rates of desired services such as preventive tests with modest cost sharing, despite having fewer office visits. Other studies that have examined the impact of HDHPs on outpatient visits show moderate, 11, 16, 17 if temporary, 17 reductions in use, although the cost-sharing requirements of visits in these studies were not clear.
Three major implications emerge from this research. First, HDHPs that exempt outpatient care from the deductible while requiring modest ($20) copayments might reduce visits for chronic conditions. Further research should examine how such patterns affect health outcomes and whether chronic visits decline due to more frequent exposure of chronically ill patients to costs associated with outpatient visits. Second, utilization was preserved for services with first-dollar coverage, such as preventive laboratory tests. Policymakers could consider selectively extending first-dollar coverage to additional high-value outpatient services, such as chronic higher-priority visits and associated general laboratory tests, to maintain use. Finally, the relative preservation of radiology tests despite full cost sharing is contrary to the generally accepted view that HDHPs broadly reduce services subject to the deductible. Future studies should examine radiology utilization in detail and attempt to differentiate between appropriate and discretionary use.
Our study has several potential limitations. First, we examined broad categories of services and the results may not be generalizable to specific services in each category. However, by examining the most common services in each category, we shed light on the services that most contributed to our results. Further, the study's comprehensive scope included outcomes absent from previous work, such as general laboratory and radiology test use. Second, we had a limited ability to understand the reasons for general laboratory or radiology test use, and thus could not comment about appropriateness of changes in utilization. Third, the findings from our controlled pre-post study could be biased if HDHP members and matched controls experienced different trends in use during the baseline period or if the control group preferentially includes members whose employers chose traditional plans because they anticipated higher utilization. However, we inspected quarterly baseline trends in use for all outcomes and found that the study groups' trajectories were always similar. Finally, our findings may not be generalizable to populations with other demographic or health compositions, or HDHPs with different cost-sharing structures. However, because we studied a typical HDHP using a strong study design, our findings should be informative for similar commercially insured and relatively high socioeconomic status populations, in addition to employers newly providing HDHPs under the ACA (see Appendix, Supplemental Digital Content 3, http://links.lww.com/MLR/A585, which includes further discussion about the issue of generalizability).
Enrollment in an HDHP was associated with both intended and unintended changes in patterns of outpatient health care utilization. In particular, higher-priority chronic outpatient visits declined, whereas no changes were detectable in preventive laboratory tests and acute visits. Future studies should examine whether chronic visits decline due to more frequent exposure of chronically ill patients to costs associated with outpatient visits, should follow a larger, nationally representative cohort over a longer period, and should examine associated changes in important proxy outcomes such as emergency department and hospital visits.
